Interpace Biosciences, Inc. (IDXG)
1.95
-0.05
(-2.50%)
USD |
OTCM |
May 08, 16:00
Interpace Biosciences Total Liabilities (Quarterly) : 11.48M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biodesix, Inc. | 85.50M |
| FONAR Corp. | 54.36M |
| Thermo Fisher Scientific, Inc. | 61.22B |
| Innovative MedTech, Inc. | 1.303M |
| Meridian Holdings, Inc. (California) | 2.631M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.84M |
| Shareholders Equity (Quarterly) | 22.36M |
| Debt to Equity Ratio | 0.0529 |
| Current Ratio | 1.94 |
| Net Debt Paydown Yield | 22.02% |